Bibliography

Research using CPRD data has informed drug safety guidance and clinical practice and resulted in over 2,300 peer-reviewed publications.

The CPRD bibliography is updated on a monthly basis (last updated 4 October 2019) and papers are listed below and in the PDF below.

If you have published papers using CPRD data which are not included in this list, please contact us at enquiries@cprd.com so that we can update the bibliography.

Download:

(PDF, 3MB, 190 pages)

 

Export 10 results:
[ Author(Desc)] Title Type Year
Filters: Author is Hagberg, K. W.  [Clear All Filters]
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 
H
K. W. Hagberg, McGlynn, K. A., Sahasrabuddhe, V. V., and Jick, S., Anti-diabetic medications and risk of primary liver cancer in persons with type II diabetes, Br J Cancer, vol. 111, pp. 1710-7, 2014.
K. W. Hagberg, Taylor, A., Hernandez, R. K., and Jick, S., Incidence of bone metastases in breast cancer patients in the United Kingdom: results of a multi-database linkage study using the general practice research database, Cancer Epidemiol, vol. 37, pp. 240-6, 2013.
K. W. Hagberg, Divan, H. A., Persson, R., Nickel, J. C., and Jick, S. S., Risk of erectile dysfunction associated with use of 5-alpha reductase inhibitors for benign prostatic hyperplasia or alopecia: population based studies using the Clinical Practice Research Datalink, Bmj, vol. 354, p. i4823, 2016.
K. W. Hagberg, Li, L., Peng, M., Paris, M., Shah, K., and Jick, S. S., Rates of Cancers and Opportunistic Infections in Patients With Psoriatic Arthritis Compared With Patients Without Psoriatic Arthritis, J Clin Rheumatol, vol. 22, pp. 241-7, 2016.
K. W. Hagberg, Li, L., Peng, M., Shah, K., Paris, M., and Jick, S., Incidence rates of suicidal behaviors and treated depression in patients with and without psoriatic arthritis using the Clinical Practice Research Datalink, Mod Rheumatol, vol. 26, pp. 774-9, 2016.
K. W. Hagberg, Sahasrabuddhe, V. V., McGlynn, K. A., and Jick, S. S., Does Angiotensin-Converting Enzyme Inhibitor and beta-Blocker Use Reduce the Risk of Primary Liver Cancer? A Case-Control Study Using the U.K. Clinical Practice Research Datalink, Pharmacotherapy, vol. 36, pp. 187-95, 2016.
K. W. Hagberg, Divan, H. A., Fang, S. C., Nickel, J. C., and Jick, S. S., Risk of gynecomastia and breast cancer associated with the use of 5-alpha reductase inhibitors for benign prostatic hyperplasia, Clin Epidemiol, vol. 9, pp. 83-91, 2017.
K. W. Hagberg, Divan, H. A., Nickel, J. C., and Jick, S. S., Risk of Incident Antidepressant-Treated Depression Associated with Use of 5alpha-Reductase Inhibitors Compared with Use of alpha-Blockers in Men with Benign Prostatic Hyperplasia: A Population-Based Study Using the Clinical Practice Research Datalink, Pharmacotherapy, vol. 37, pp. 517-527, 2017.
K. W. Hagberg and Jick, S. S., Validation of autism spectrum disorder diagnoses recorded in the Clinical Practice Research Datalink, 1990-2014, Clin Epidemiol, vol. 9, pp. 475-482, 2017.
K. W. Hagberg, Robijn, A. L., and Jick, S., Maternal depression and antidepressant use during pregnancy and the risk of autism spectrum disorder in offspring, Clin Epidemiol, vol. 10, pp. 1599-1612, 2018.
[Page last reviewed 4 October 2019]